Atrial Septal Defect Increases the Risk for Stroke After Total Hip Arthroplasty

Dean C Perfetti1, Morad Chughtai2, Matthew R Boylan3

  • 1Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, New York.

Insights

Patients with atrial septal defect (ASD) or patent foramen ovale (PFO) undergoing total hip arthroplasty (THA) face a significantly higher risk of perioperative acute ischemic stroke (AIS). This highlights the need for pre-operative risk discussion.

Area of Science:

  • Cardiology
  • Orthopedic Surgery
  • Neurology

Background:

  • Atrial septal defect (ASD) and patent foramen ovale (PFO) are common congenital heart conditions.
  • These defects pose risks for perioperative acute ischemic stroke (AIS) via paradoxical emboli.

Purpose of the Study:

  • To determine ASD/PFO prevalence in total hip arthroplasty (THA) patients.
  • To assess perioperative AIS rates in THA patients with ASD/PFO.
  • To compare AIS risk in THA patients with ASD/PFO versus controls.

Main Methods:

  • Analysis of 393,652 THA patients from the Nationwide Inpatient Sample (2007-2013).
  • Identification of ASD/PFO and perioperative AIS using ICD-9-CM codes.
  • Propensity score matching of 252 ASD/PFO patients with 756 controls.

Main Results:

  • ASD/PFO prevalence was 64 per 100,000 THA patients.
  • AIS rate was 7.14% in ASD/PFO patients vs. 0.26% in controls (P < .001).
  • ASD/PFO increased AIS risk by 29-fold (OR, 29.00; P < .001).

Conclusions:

  • THA patients with ASD/PFO have substantially elevated perioperative AIS risk.
  • Orthopedic surgeons must discuss this risk pre-operatively.
  • Further research is needed on thromboprophylaxis for ASD/PFO patients.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
647
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
403
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
956
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
518
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
376
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
848